Peter M. Irving, MD

IBD Unit, Guy’s and St Thomas’ Hospital, London, UK, United Kingdom

Poster(s):

• P3315 - Mirikizumab Provides Sustained Long-Term Efficacy Up to 4 Years of Treatment for Ulcerative Colitis: Final Results From the LUCENT-3 Open-Label Extension Study
  Monday, October 27, 2025

  10:30 AM - 4:00 PM PDT